Pa. Justices Snub Appeal Over $2.5M Risperdal Verdict

Law360 (August 2, 2019, 6:31 PM EDT) -- The Pennsylvania Supreme Court on Friday said it will not hear arguments from a Johnson & Johnson unit over a $2.5 million verdict awarded to the family of an autistic Alabama boy who grew breasts after taking the antipsychotic drug Risperdal.

J&J subsidiary Janssen Pharmaceuticals Inc. asked the justices to review the case after the state's Superior Court upheld a jury's findings in October that the company had failed to adequately warn physicians about the heightened risk of hormone spikes in adolescent boys using the powerful drug.

The justices did not comment on the case in turning down the appeal.

The case, brought...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!